Ventas (VTR) is up 5.4% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to renewed investor focus on Ventas’ senior housing momentum and its 2026 outlook after the company circulated updated presentation materials and business metrics ahead of major investor meetings. Even with a choppy macro backdrop, the stock can react sharply when healthcare REIT investors see clearer evidence of accelerating senior-housing cash flows and disciplined capital plans.
Details:
Sources:
Ventas Investor Relations, Business Wire, Nareit
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$VTR Insider Trading Activity
$VTR insiders have traded $VTR stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $VTR stock by insiders over the last 6 months:
- CAREY S. ROBERTS (EVP and GC) sold 35,532 shares for an estimated $3,020,116
- ROBERT F PROBST (EVP and CFO) sold 29,930 shares for an estimated $2,312,188
- DEBRA A CAFARO (Chairman and CEO) sold 10,322 shares for an estimated $797,474
- MICHAEL J EMBLER purchased 2,500 shares for an estimated $197,025
- WALTER C RAKOWICH sold 1,152 shares for an estimated $103,915
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$VTR Hedge Fund Activity
We have seen 493 institutional investors add shares of $VTR stock to their portfolio, and 397 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA INVESTMENTS, LP added 2,368,708 shares (+145.8%) to their portfolio in Q1 2026, for an estimated $193,712,940
- CAPITAL WORLD INVESTORS added 2,365,967 shares (+30.8%) to their portfolio in Q1 2026, for an estimated $193,488,781
- VANGUARD GROUP INC added 2,349,176 shares (+3.2%) to their portfolio in Q4 2025, for an estimated $181,779,238
- FMR LLC removed 2,029,740 shares (-6.9%) from their portfolio in Q1 2026, for an estimated $165,992,137
- JPMORGAN CHASE & CO removed 1,574,836 shares (-5.3%) from their portfolio in Q4 2025, for an estimated $121,860,809
- BLACKROCK, INC. added 1,489,789 shares (+2.7%) to their portfolio in Q1 2026, for an estimated $121,834,944
- TWO SIGMA ADVISERS, LP added 1,466,162 shares (+1850.1%) to their portfolio in Q4 2025, for an estimated $113,451,615
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$VTR Congressional Stock Trading
Members of Congress have traded $VTR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $VTR stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$VTR Price Targets
Multiple analysts have issued price targets for $VTR recently. We have seen 11 analysts offer price targets for $VTR in the last 6 months, with a median target of $95.0.
Here are some recent targets:
- John Kilichowski from Wells Fargo set a target price of $96.0 on 06/01/2026
- Nicholas Yulico from Scotiabank set a target price of $95.0 on 05/21/2026
- Jonathan Petersen from Jefferies set a target price of $100.0 on 05/13/2026
- Michael Mueller from JP Morgan set a target price of $94.0 on 05/11/2026
- Todd M. Thomas from Keybanc set a target price of $95.0 on 05/07/2026
- Michael Carroll from RBC Capital set a target price of $98.0 on 05/04/2026
- Michael Goldsmith from UBS set a target price of $93.0 on 05/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.